Structured evidence table for Pistachio Cholesterol Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Pistachio Cholesterol Randomized Trial | The studies were heterogeneous in terms of intervention and biomarkers assessed, and all of them had moderate-to-high risk of bias. | 1 | Lazzarin T (2025) | Nut consumption in chronic kidney disease: a systematic review. |
| Pistachio Cholesterol Randomized Trial | Overall the findings indicate positive effects of Brazil nuts and baru almond oil on oxidative stress and inflammation markers, while walnuts reduced LDL cholesterol and blood pressure while posing no risk regarding electrolytes balance. | 1 | Lazzarin T (2025) | Nut consumption in chronic kidney disease: a systematic review. |
| Pistachio Cholesterol Randomized Trial | Further, the consumption of total nuts was associated with reduction in all-cause mortality. | 1 | Lazzarin T (2025) | Nut consumption in chronic kidney disease: a systematic review. |
| Pistachio Cholesterol Randomized Trial | Introduction Nuts possess a beneficial nutritional profile with antioxidant and anti-inflammatory properties, potentially improving health outcomes in chronic kidney disease (CKD) patients. | 1 | Lazzarin T (2025) | Nut consumption in chronic kidney disease: a systematic review. |
| Pistachio Cholesterol Randomized Trial | Diets high in free sugars, particularly from sugar-sweetened beverages (SSBs), are associated with abdominal obesity and increased cardiometabolic risk, prompting global guidelines to limit SSBs as a major public health strategy. | 2 | Erlich MN (2026) | Rationale, Design, and Participant Baseline Characteristics of a Parallel Randomized Trial of the Effect of Replacing SSBs with Cow's Milk Versus Soymilk on Intrahepatocellular Lipid and Other Cardiometabolic Risk Factors in Adults with Obesity Who Consume Sugar-Sweetened Beverages: The Soy Treatment Evaluation for Metabolic health (STEM) Trial. |
| Pistachio Cholesterol Randomized Trial | Fortified soymilk is a plant-based alternative with approved health claims for cholesterol and coronary heart disease risk reduction that offers an equivalent nutritional value to cow's milk. | 2 | Erlich MN (2026) | Rationale, Design, and Participant Baseline Characteristics of a Parallel Randomized Trial of the Effect of Replacing SSBs with Cow's Milk Versus Soymilk on Intrahepatocellular Lipid and Other Cardiometabolic Risk Factors in Adults with Obesity Who Consume Sugar-Sweetened Beverages: The Soy Treatment Evaluation for Metabolic health (STEM) Trial. |
| Pistachio Cholesterol Randomized Trial | The Soy Treatment Evaluation for Metabolic (STEM) health trial seeks to evaluate the impact of replacing SSBs with either 2% soymilk or 2% cow's milk on liver fat and other cardiometabolic risk factors in habitual adult consumers of SSBs with obesity. | 2 | Erlich MN (2026) | Rationale, Design, and Participant Baseline Characteristics of a Parallel Randomized Trial of the Effect of Replacing SSBs with Cow's Milk Versus Soymilk on Intrahepatocellular Lipid and Other Cardiometabolic Risk Factors in Adults with Obesity Who Consume Sugar-Sweetened Beverages: The Soy Treatment Evaluation for Metabolic health (STEM) Trial. |
| Pistachio Cholesterol Randomized Trial | Background/Objectives : Liver fat represents an early metabolic lesion in the development of diabetes and its cardiometabolic complications. | 2 | Erlich MN (2026) | Rationale, Design, and Participant Baseline Characteristics of a Parallel Randomized Trial of the Effect of Replacing SSBs with Cow's Milk Versus Soymilk on Intrahepatocellular Lipid and Other Cardiometabolic Risk Factors in Adults with Obesity Who Consume Sugar-Sweetened Beverages: The Soy Treatment Evaluation for Metabolic health (STEM) Trial. |
Source documents